NEWS & MEDIA

Press Releases

4/2/2026

Myopharm CRO Appointment

Read Announcement

24/12/2025

Myopharm December Update

Read Announcement

17/11/2025

Myopharm Strengthens Clinical Team & Appoints Dr Charles Czank.

Read Announcement

6/8/2025

TriGlytza® achieves significant reduction in HbA1c % in Pre-Clinical Type 2 Diabetes

Read Announcement

25/7/2025

Myopharm Appoints Dr Trevor Lockett to the Board of Directors

Read Announcement

16/7/2025

Myopharm Clinical & Preclinical Trials and Partnership Update

Read Announcement

20/6/2025

3-YEAR PARTNERSHIP SIGNED WITH DIABETES AUSTRALIA

Read Announcement

13/6/2025

2024 Annual Report & Financial Statements

Read Announcement

7/5/2025

MARCH 2025 QUARTERLY REPORT

Read Announcement

17/3/2025

Dr George Tachas and Advait Padhye joins Myopharm’s Scientific Team

Read Announcement

6/2/2025

Myopharm strengthens clinical development team with appointment of Tamara Miller

Read Announcement

Reports

Baker - IDI Report The Chronic Study

View Report

Baker - IDI Report The Acute Study

View Report

Nutrition Journal

View Report

Bioshares 952 Myopharm

View Report

Follow us

Subscribe to email alerts
CONTACT US